Sepideh Panahi, MD
Neurology · Washington, DCNPI 1083032304
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,837 of the $2,187 with a category attached, or 84.0%. 23 manufacturers reported payments, led by AbbVie at 26.7% of the total. Reporting peaked in 2019 at $741 and has fallen 63.4% since, to $271 in 2025.
Across 88 payments — averaging $24.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$584
- Sanofi$350
- MDD US Operations, LLC$167
- Acadia Pharmaceuticals Inc$164
- Medtronic$121
- Eisai Inc.$101
- plus $700 from 17 others
What the payments were for
- Speaking & faculty fees$35016%
- Food & beverage$1,83784%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $584 |
| Sanofi | 1 | $350 |
| MDD US Operations, LLC | 3 | $167 |
| Acadia Pharmaceuticals Inc | 4 | $164 |
| Medtronic | 1 | $121 |
| Eisai Inc. | 1 | $101 |
| Sunovion Pharmaceuticals Inc. | 6 | $99 |
| Amneal Pharmaceuticals LLC | 5 | $79 |
| Novartis | 5 | $60 |
| Neurocrine Biosciences, Inc. | 4 | $56 |
| Argenx US, Inc. | 2 | $55 |
| Amgen | 3 | $46 |
| Greenwich Biosciences, Inc. | 1 | $45 |
| Upsher-smith Laboratories LLC | 3 | $44 |
| Adamas Pharmaceuticals, Inc. | 3 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Kyowa Kirin, Inc. | 2 | $28 |
| Lilly USA, LLC | 2 | $26 |
| Avion Pharmaceuticals | 1 | $24 |
| Biogen | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| UCB, Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$125
- Reveal LINQ$121
- BOTOX$111
- Leqembi$101
How this compares
$2,187 in reported general payments places this provider in the 55th percentile of 113 neurology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Washington
- Laxman BahrooWashington$3.1M
- Fahd AmjadWashington$2M
- Jessica AilaniWashington$1.2M
- Yasar Torres-YaghiWashington$969K
- Benjamin OsborneWashington$747K
- Fernando PaganWashington$690K
- Faria AmjadWashington$557K
- Brian BarryWashington$359K
- Carrie DoughertyWashington$327K
- Carlo TornatoreWashington$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.